Medical device, pharmaceutical business, IT and industry investments

azure 200

New technologies for drugs and biomaterials stabilization

irisbond 200

Computer control technology by eye movement

3D scanning technology that uses structured white light

palobiofarma

Drugs to improve people’s life quality suffering from neurodegenerative and respiratory diseases

signadyne 200

Test, measurement and control electronic equipment

Our Strategy

We look for investment opportunities relying on committed teams and innovative technology. Our technology scope ranges from IT to Manufacturing, Energy, Biotechnology, Pharma and Digital Business, as long as the target company has already developed a product or it is preclinical phase in case of Bio/Pharma leads.

Who we are

Fitalent (FIT Inversión en Talento SCR de Régimen Simplificado SL) is a venture capital firm incorporated in 2011 and registered in the Spanish Securities and Exchange Commission (CNMV). FIT is the result of the bet on entrepreneurship and young talent carried out by everis group (www.everis.com), being our mission to support entrepreneurs to transform their ventures into profitable, leading companies.

everis is a multinational consulting firm providing business and strategy solutions, application development, maintenance, and outsourcing services. Established in 1996, everis has averaged 20% annual growth in revenues and became part of NTT Data in January, 2014.

Contact us

Name (required)

email (required)

Subject

Message